web analytics

Description

Some patients with loiasis will develop an encephalitis during chemotherapy with diethylcarbamazine (DEC). This may be associated with morbidity and mortality, so is best avoided.


 

Factors affecting host response:

(1) sudden release of antigenic material

(2) migration of microfilaria through the central nervous system

 

Risk factors for encephalitis:

(1) high density of microfilaria in the peripheral blood (especially if > 30,000 per mL) when chemotherapy is started

(2) high initial dose of deithylcarbamazine (DEC)

(3) rapid escalation in DEC dose

(4) failure to provide anti-allergic therapy

 

Reducing the microfilarial load by apheresis prior to starting DEC chemotherapy can significantly reduce neurological complications.

 

Ivermectin has been associated with a lower risk of neurologic complications, but risks occur with hypermicrofilaremic loads.

 


To read more or access our algorithms and calculators, please log in or register.